LPL Financial LLC Has $2.23 Million Position in Koninklijke Philips N.V. $PHG

Key Points

• LPL Financial LLC has reduced its stake in Koninklijke Philips N.V. by 12.0%, now holding a total of 87,907 shares valued at approximately $2.23 million.
• Despite LPL's cut, other institutional investors, such as QRG Capital Management and Cerity Partners, have increased their positions in Koninklijke Philips, reflecting a mixed sentiment among hedge funds.
• Shares of Koninklijke Philips saw a 0.4% increase recently, with a current market cap of $26.54 billion and a P/E ratio of 145.08.

LPL Financial LLC lowered its position in Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 12.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 87,907 shares of the technology company's stock after selling 12,004 shares during the period. LPL Financial LLC's holdings in Koninklijke Philips were worth $2,233,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the business. QRG Capital Management Inc. increased its stake in shares of Koninklijke Philips by 11.0% during the 1st quarter. QRG Capital Management Inc. now owns 142,595 shares of the technology company's stock worth $3,622,000 after purchasing an additional 14,090 shares during the last quarter. Aurora Private Wealth Inc. acquired a new stake in shares of Koninklijke Philips in the 1st quarter valued at $1,695,000. Quantinno Capital Management LP boosted its holdings in Koninklijke Philips by 71.1% in the fourth quarter. Quantinno Capital Management LP now owns 180,149 shares of the technology company's stock worth $4,561,000 after purchasing an additional 74,835 shares in the last quarter. Cerity Partners LLC increased its position in Koninklijke Philips by 30.6% during the first quarter. Cerity Partners LLC now owns 80,767 shares of the technology company's stock worth $2,051,000 after buying an additional 18,906 shares during the last quarter. Finally, HB Wealth Management LLC acquired a new position in Koninklijke Philips during the first quarter worth $333,000. 13.67% of the stock is currently owned by institutional investors and hedge funds.

Koninklijke Philips Stock Performance

Koninklijke Philips stock traded up $0.8750 on Friday, reaching $28.3150. 835,595 shares of the stock were exchanged, compared to its average volume of 1,158,058. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.69. Koninklijke Philips N.V. has a twelve month low of $21.48 and a twelve month high of $32.91. The firm has a fifty day moving average price of $25.22 and a two-hundred day moving average price of $24.99. The stock has a market cap of $27.27 billion, a PE ratio of 149.03, a PEG ratio of 0.77 and a beta of 0.75.

Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.12. Koninklijke Philips had a return on equity of 11.95% and a net margin of 1.00%.The business had revenue of $5.05 billion during the quarter, compared to analysts' expectations of $4.35 billion. Sell-side analysts anticipate that Koninklijke Philips N.V. will post 1.63 EPS for the current year.

Analyst Ratings Changes

Separately, Wall Street Zen cut Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, Koninklijke Philips has a consensus rating of "Buy".

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.